Terms ending in 2027
Every in-force patent on ZymoGenetics Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,514,077 | Methods of Antagonizing Signal Transduction in Dorsal Root Ganglion Cells with IL-31 Antagonists In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 7,638,126 | Methods of Treating Pain and Inflammation in Neuronal Tissue Using Antagonists of IL-31, IL-31RA And/Or Osmrb In force · High confidence | ZymoGenetics, Inc. | In force | High confidence | |
| US 8,637,015 | Methods of Antagonizing Signal Transduction in Dorsal Root Ganglion Cells In force · Low confidence | ZymoGenetics, Inc. | In force | Low confidence | |
| US 8,685,395 | Methods of Antagonizing Signal Transduction in Dorsal Root Ganglion Cells In force · Low confidence | ZymoGenetics, Inc. | In force | Low confidence | |
| US 8,968,732 | Methods of Treating Pain Using an IL-31 Monoclonal Antibody In force · Medium confidence | ZymoGenetics, Inc. | In force | Medium confidence | |
| US 8,974,783 | Methods of Treating Pain Using an IL-31RA or Osmr-B Antagonist In force · Low confidence | ZymoGenetics, Inc. | In force | Low confidence | |
| US 9,334,321 | Methods of Treating Neuronal Inflammation Using an IL-31 Monoclonal Antibody In force · Low confidence | ZymoGenetics, Inc. | In force | Low confidence | |
| US 9,334,322 | Methods of Antagonizing Signal Transduction in Spinal Cord Cells Using an IL-31RA or Osmr-B Antagonist In force · Medium confidence | ZymoGenetics, Inc. | In force | Medium confidence | |
| US 9,631,021 | Use of an IL-31 Monoclonal Antibody for Antagonizing Signal Transduction in Spinal Cord Cells In force · Medium confidence | ZymoGenetics, Inc. | In force | Medium confidence | |
| US 9,631,022 | Method Treating Neuronal Tissue Inflammation Using an IL-31RA Monoclonal Antibody In force · Low confidence | ZymoGenetics, Inc. | In force | Low confidence | |
| 16 more term ends in 2027 · Pro | |||||
10 of 26 patents shown. Soonest term end first, then patent number.
Pro members see all 26, all of them expiring within the 18 months from Nov 18, 2026.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.